BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
SOM Biotech
/
Rossella Medori, M.D
RM
Rossella Medori, M.D
Chief Medical Officer
SOM Biotech
Therapeutic Areas
Neurology
Psychiatry
SOM Biotech Pipeline
Drug
Indication
Phase
SOM3355
Huntington's disease
Phase 3
SOM1311
Phenylketonuria (PKU)
Preclinical
SOM3366
Tourette Syndrome
Preclinical
SOM0226
TTR Amyloidosis
Phase 2a PoC
Leadership Team at SOM Biotech
SP
Silvia Panigone, Ph.D, MBA
CEO and Board Member
KM
Kevin McAllister, Ph.D, MBA
Chief Scientific Officer
OH
Oscar Huertas, M.Sc
Chief Technology Officer
View full SOM Biotech profile